Femmeola 150mg Tablet 30's

Femmeola 150mg Tablet 30's is a cancer medication belonging to the class of PARP (poly [adenosine diphosphate-ribose] polymerase) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. This medication may be administered alone or in combination with other anticancer medications. Olaparib is not recommended if you are allergic to the active compound or other ingredients of the medicine. Contact your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before treatment begins and every month during treatment, as this medicine may reduce counts of red blood cells, white blood cells, and platelets. Inform your healthcare provider before starting treatment if you have been diagnosed with problems affecting your lungs, liver, heart, or kidneys. This medication is not advised during pregnancy as it may harm the fetus and cause miscarriage. Women of reproductive age should obtain a pregnancy test before beginning this medication. It is preferable to continue using birth control for at least six months after treatment completion. Breastfeeding is not advised during treatment as it is unknown whether Femmeola 150mg Tablet 30's passes into breast milk. Men should not donate sperm for at least 3 months after treatment completion. Inform your doctor about all medicines you are taking, including prescription medications, over-the-counter drugs, vitamins, and supplements.

Treatment of Prostate cancer Metastatic Pancreatic cancer

Femmeola 150mg Tablet 30's works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Femmeola 150mg Tablet 30's prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.

The medicine will be prescribed to you by a healthcare professional in a hospital setting. Femmeola 150mg Tablet 30's is available as a tablet to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Femmeola 150mg Tablet 30's at the same time every day.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems Common Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache

Femmeola 150mg Tablet 30's can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Femmeola 150mg Tablet 30's should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Femmeola 150mg Tablet 30's. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Femmeola 150mg Tablet 30's can be an effective treatment option for certain types of cancer.